Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 4351 - 4375 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU01
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260964 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC01
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260988 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ01
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • galgactosyl-paraglobside(d18:1/16:0)
 44261252 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK01
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261260 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AN01
  • Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261916 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS01
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • iGb5(d18:1/16:0)
 44261580 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU01
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261596 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BE01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261660 1388.802768 C66H120N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU03
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260326 1387.843904 C68H125NO27
Glycosyldiacylglycerols LMGL05010071
  • 1-(9Z-octadecenoyl)-2-(9,10-methylene-octadecanoic acid)-3-O-beta-d-glucopyranosyl-(1->6)-alpha-d-galactopyranosyl-(6-(9Z-octadecenoyl))-(1->2)-alpha-d-glucosyl-sn-glycerol
  • 1-oleoyl-2-Dihydrosterculoyl-3-O-beta-d-glucopyranosyl-(1->6)-alpha-d-galactopyranosyl-(6-(9Z-octadecenoyl))-(1->2)-alpha-d-glucosyl-sn-glycerol
 171118824 1384.957415 C76H136O21
Gangliosides LMSP0601AM02
  • GM2(d18:1/18:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262061 60327 1383.823837 C67H121N3O26
Gangliosides LMSP0601EK02
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262829 1383.823837 C67H121N3O26
Monoacylglycerophosphoinositolglycans LMGP15040033
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM5(16:0/0:0)
 126457690 1382.560293 C55H99O37P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN05
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44260592 1379.901692 C70H129N3O23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN07
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44260594 1377.886042 C70H127N3O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM02
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44260261 1375.807519 C66H121NO28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260548 1372.807853 C66H120N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC01
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lewis a(d18:1/16:0)
 44260628 1372.807853 C66H120N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD01
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type I H antigen(d18:1/16:0)
 44260636 1372.807853 C66H120N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB01
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lex-5(d18:1/16:0)
 44260980 1372.807853 C66H120N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD01
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type II antigen(d18:1/16:0)
 44260996 1372.807853 C66H120N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV01
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261604 1372.807853 C66H120N2O27
Gangliosides LMSP0601CI01
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 52931289 1371.787452 C65H117N3O27
Gangliosides LMSP0601DC03
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44262574 1370.828588 C67H122N2O26
Gangliosides LMSP0601DG03
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • KDN-GM2(d18:1/20:0)
 44262606 1370.828588 C67H122N2O26
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024